Information Provided By: 
Fly News Breaks for March 10, 2017
LJPC
Mar 10, 2017 | 09:45 EDT
Chardan said it has increased confidence in Top Pick La Jolla Pharmaceutica following meetings wit CEO, George F. Tidmarsh, MD, PhD, while the company was on a roadshow to meet with investors and analysts. The firm's analyst came away from the meeting more positive on the company's de-risked strategy towards drug development, and believes the potential of the strategy is supported by the recent success of LJPC-501 in catecholamine resistant hypotension in its pivotal phase III study, ATHOS-3.
News For LJPC From the Last 2 Days
There are no results for your query LJPC
